These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14288089)

  • 41. [Reversible acute renal failure in minimal-change glomerular nephrotic syndrome].
    Millán I; Torre A; Picazo ML; Martínez Ara J
    Nefrologia; 2001; 21(4):413-5. PubMed ID: 11816521
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro calcification of rachitic rat cartilage in normal and pathological human sera with some observations on the pathogenesis of renal rickets.
    YENDT ER; CONNOR TB; HOWARD JE
    Bull Johns Hopkins Hosp; 1955 Jan; 96(1):1-19. PubMed ID: 13230696
    [No Abstract]   [Full Text] [Related]  

  • 43. [Vitamin-resistant rickets].
    ROYER P
    Gaz Med Fr; 1957 Jan; 64(1):39-40; passim. PubMed ID: 13405171
    [No Abstract]   [Full Text] [Related]  

  • 44. [Attempted anatomoclinical comparison in glomerular nephropathies in children. (Apropos of 45 cases of renal biopsy)].
    GIRAUD P; BERNARD R; COIGNET J; MURATORE R; MAESTRAGGI P; KNEBELMAN C; MURISASCO A; JAUBERT R
    Pediatrie; 1963; 18():135-42. PubMed ID: 13948180
    [No Abstract]   [Full Text] [Related]  

  • 45. ROLE OF PHOSPHATE IN TREATMENT OF RENAL TUBULAR (HYPOPHOSPHATAEMIC) RICKETS AND OSTEOMALACIAS.
    ROSE GA
    Br Med J; 1964 Oct; 2(5413):857-61. PubMed ID: 14185638
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapy of the nephrotic syndrome in children].
    Linneweh F
    Minerva Med; 1973 Oct; 64(76):4007-9. PubMed ID: 4764071
    [No Abstract]   [Full Text] [Related]  

  • 47. [INTRODUCTION TO THE STUDY OF THE PATHOLOGY OF INTESTINAL ABSORPTION OF CALCIUM].
    CANIGGIA A; GENNARI C
    Minerva Med; 1964 Nov; 55():3765-82. PubMed ID: 14241932
    [No Abstract]   [Full Text] [Related]  

  • 48. [Considerations on nephrosis and nephrotic syndrome].
    CASTEX MR
    Prensa Med Argent; 1949 Oct; 36(40):1993-2005. PubMed ID: 15392252
    [No Abstract]   [Full Text] [Related]  

  • 49. THE NEPHROTIC SYNDROME: BIOCHEMICAL ALTERATIONS AND THERAPY.
    KREHL WA; MURPHY FD
    Biochem Clin; 1963; 2():385-99. PubMed ID: 14095808
    [No Abstract]   [Full Text] [Related]  

  • 50. [On the problem of clinical and electrolyte-chemical features in the course of corticosteroid therapy of nephrosis].
    BECKMANN R; HASTREITER AR
    Monatsschr Kinderheilkd (1902); 1960 May; 108():265-8. PubMed ID: 13798167
    [No Abstract]   [Full Text] [Related]  

  • 51. [Renal osteopathy, rachitis and vitamin D].
    Müller H
    Med Klin; 1975 Feb; 70(6):3-4. PubMed ID: 1124037
    [No Abstract]   [Full Text] [Related]  

  • 52. HEMODIALYSIS IN INFANTILE NEPHROTIC SYNDROME. A CASE REPORT DESCRIBING A NEW HEMODIALYSIS SYSTEM.
    WALKER CH; WERSHING JM; SIMONS SL; HOLMES JH; SITPRIJA V; O'BRIEN D
    Am J Dis Child; 1963 Nov; 106():479-83. PubMed ID: 14077165
    [No Abstract]   [Full Text] [Related]  

  • 53. THE TREATMENT OF NEPHROSIS.
    SAXENA KM; CRAWFORD JD
    N Engl J Med; 1965 Mar; 272():522-6. PubMed ID: 14253674
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of nephrotic syndrome.
    Arneil GC
    Turk J Pediatr; 1973 Jan; 15(1):52-66. PubMed ID: 4616430
    [No Abstract]   [Full Text] [Related]  

  • 55. [Histopathological base of the nephrotic syndrome in the child and the adult. Frequency of the different lesions and their repercussions in the corticoid therapy].
    MIATELLO VR; MOLEDO LI; MORELLI OH; FALCON OI
    Rev Asoc Med Argent; 1962 Jul; 76():311-3. PubMed ID: 14473301
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of two prophylactic bolus vitamin D dosing regimens (1000 IU/day vs. 400 IU/day) on bone mineral content in new-onset and infrequently-relapsing nephrotic syndrome: a randomised clinical trial.
    Muske S; Krishnamurthy S; Kamalanathan SK; Rajappa M; Harichandrakumar KT; Sivamurukan P
    Paediatr Int Child Health; 2018 Feb; 38(1):23-33. PubMed ID: 28466679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Membranoproliferative glomerulonephritis and persistent hypocomplementaemia.
    Cameron JS; Glasgow EF; Ogg CS; White RH
    Br Med J; 1970 Oct; 4(5726):7-14. PubMed ID: 4097129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [RENAL INVOLVEMENT IN THE SCHOENLEIN-HENOCH SYNDROME. (CLINICAL DATA AND LONG-TERM OBSERVATIONS ON 17 CASES)].
    GUAZZELLI C
    Riv Clin Pediatr; 1963 Dec; 72():439-56. PubMed ID: 14166936
    [No Abstract]   [Full Text] [Related]  

  • 59. Predictors of outcome in Henoch-Schönlein nephritis in children and adults.
    Coppo R; Andrulli S; Amore A; Gianoglio B; Conti G; Peruzzi L; Locatelli F; Cagnoli L
    Am J Kidney Dis; 2006 Jun; 47(6):993-1003. PubMed ID: 16731294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Purpura of the urinary tract, focal nephritis and Bright's disease; the problem of renal hematuria].
    GUNTHER GW
    Z Urol; 1950; 43(11-12):496-520. PubMed ID: 14818401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.